Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.

Patil NK, Bohannon JK, Sherwood ER
Pharmacol Res. 2016 111: 688-702

PMID: 27468649 · PMCID: PMC5026606 · DOI:10.1016/j.phrs.2016.07.019

MeSH Terms (11)

Adaptive Immunity Animals Biomarkers Humans Immunocompromised Host Immunologic Factors Immunotherapy Patient Selection Predictive Value of Tests Sepsis T-Lymphocytes

Connections (1)

This publication is referenced by other Labnodes entities: